US FDA declines to approve Y-mAbs’s paediatric cancer drug
Y-mAbs said it is assessing the implications of the Food and Drug Administration's (FDA) Complete Response Letter (CRL) and the…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.